Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Renalytix plc (LSE:RENX) Shares Rise 5.66%: What's Behind the Move and What Comes Next

Renalytix is an AI-driven diagnostics business focused on kidney health. Its lead product, KidneyIntelX, combines clinical data, biomarkers and machine learning to identify patients at risk of progressive chronic kidney disease well before traditional markers would flag a problem. The platform is aimed at …

Ankur Sharma | 28 July 2026

Can One Health Group plc Sustain Its Momentum?

Important valuation considerations include:

Ishan Mudgal | 28 July 2026

Can Poolbeg Pharma plc Sustain Its Momentum?

Important valuation considerations include:

Ishan Mudgal | 28 July 2026

Can Kooth plc Sustain Its Momentum?

Important valuation considerations include:

Ishan Mudgal | 28 July 2026

Can Haleon plc Sustain Its Momentum?

Recent Share Price Change:Haleon plc shares (HLN) recently increased by +1.51%, moving +5.60 to GBX 375.80.

Ishan Mudgal | 28 July 2026

Can Convatec Group plc Sustain Its Momentum?

Recent Share Price Change:Convatec Group plc shares (CTEC) recently increased by +0.82%, moving +1.80 to GBX 222.00.

Ishan Mudgal | 28 July 2026

LSE:GSK Share Price Surges Ahead of Key Business Growth Expectations

LSE:GSK – GSK plcattracted significant investor attention after its shares climbed approximately6.02%during trading on28 July 2026.

Ankur Sharma | 28 July 2026

RUA Life Sciences Plc Share Price Jumps: Is LSE:RUA Building Fresh Momentum?

LSE:RUA – RUA Life Sciences Plcattracted strong investor attention after its shares advanced approximately5.90%during trading on28 July 2026.

Ankur Sharma | 28 July 2026

Oxford BioDynamics (LSE: OBD): Prostate-Test Sales Jump 126%, but a Going-Concern Warning Demands Fresh Cash by Late August

Oxford BioDynamics Plc (LSE/AIM: OBD) has a genuine scientific asset and an acute financial problem, and its interim results on 30 June 2026 put both on display. Sales of its flagship prostate blood test are climbing fast, a new chief executive from the genomics …

Divya Sood | 28 July 2026

GENinCode (LSE: GENI): Thermo Fisher Deal and Q3 FDA Push Meet Going-Concern Doubt as Shares Sink to Record Lows

GENinCode PLC (LSE: GENI) is the kind of stock where the science reads more encouragingly than the share price. On 24 July 2026 the shares changed hands at just 0.825 pence, valuing the whole company at roughly £6.0m and sitting only fractionally above the …

Divya Sood | 28 July 2026
Support

Hi! How can we help you today?

Loading…